Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
Leonardo Mirandola, Maurizio Chiriva‐Internati(Texas Tech University), Robert S. Bresalier(The University of Texas MD Anderson Cancer Center), Raffaella Chiaramonte(University of Milan), M. Colombo(Human Technopole), Federica Patrinicola(Humanitas University), Fabio Grizzi(Humanitas University), Naval Daver(The University of Texas MD Anderson Cancer Center), Peter P. Ruvolo(The University of Texas MD Anderson Cancer Center), W. Martin Kast(University of Southern California), Elisa Pedretti, Rakhshanda Layeequr Rahman(Texas Tech University), Sean M. Post(The University of Texas MD Anderson Cancer Center), Diane Nguyen(Texas Tech University), José A. Figueroa(Texas Tech University), Caroline Chapman(University of Oxford)
Cited by 21
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840